Low-Dose IL-2 Therapy in Autoimmune and Rheumatic Diseases.
Front Immunol. 2021 Apr 1;12:648408. doi: 10.3389/fimmu.2021.648408. eCollection 2021.
Front Immunol. 2021.
PMID: 33868284
Free PMC article.
Review.